Lipids and Lipoproteins in Patients With Type 2 Diabetes
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Insulin resistance and type 2 diabetes are associated with a clustering of interrelated plasma lipid and lipoprotein abnormalities, which include reduced HDL cholesterol, a predominance of small dense LDL particles, and elevated triglyceride levels. Each of these dyslipidemic features is associated with an increased risk of cardiovascular disease. Increased hepatic secretion of large triglyceride-rich VLDL and impaired clearance of VLDL appears to be of central importance in the pathophysiology of this dyslipidemia. Small dense LDL particles arise from the intravascular processing of specific larger VLDL precursors. Typically, reduced plasma HDL levels in type 2 diabetes are manifest as reductions in the HDL2b subspecies and relative or absolute increases in smaller denser HDL3b and HDL3c. Although behavioral interventions such as diet and exercise can improve diabetic dyslipidemia, for most patients, pharmacological therapy is needed to reach treatment goals. There are several classes of medications that can be used to treat lipid and lipoprotein abnormalities associated with insulin resistance and type 2 diabetes, including statins, fibrates, niacin, and thiazolidinediones. Clinical trials have shown significant improvement in coronary artery disease after diabetic dyslipidemia treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
A Randomized Trial of a Low-Carbohydrate Diet for Obesity
Foster, G. D., Wyatt, H. R., Hill, J. O., McGuckin, B. G., Brill, C., Mohammed, B. S., Szapary, P. O., Rader, D. J., Edman, J. S., & Klein, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022207 · Cited by 1,794
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
Effects of the amount and intensity of exercise on plasma lipoproteins
Kraus, W. E., Houmard, J. A., Duscha, B. D., Knetzger, K. J., Wharton, M. B., McCartney, J. S., Bales, C. W., Henes, S., Samsa, G. P., Otvos, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020194 · Cited by 1,554
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Self-citationManninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moyé, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.23.2513 · Cited by 986
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Self-citationHaskell, W. L., Alderman, E. L., Fair, J. M., Maron, D. J., Mackey, S. F., Superko, H. R., Williams, P. T., Johnstone, I. M., Champagne, M. A., & Krauss, R. M. (1994) · Circulation · doi:10.1161/01.cir.89.3.975 · Cited by 884
Self-citationAssmann, G., & Schulte, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90550-i · Cited by 872
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843
Miyazaki, Y., Mahankali, A., Matsuda, M., Mahankali, S., Hardies, J., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8567 · Cited by 726
de Graaf, J., Hak-Lemmers, H. L., Hectors, M. P., Demacker, P. N., Hendriks, J. C., & Stalenhoef, A. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Reaven, G. M., Chen, Y. D., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 690
Self-citationMayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., Enocksson, S., Inzucchi, S. E., Shulman, G. I., & Petersen, K. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.797 · Cited by 647
Aronoff, S., Rosenblatt, S., Braithwaite, S., Egan, J. W., Mathisen, A. L., & Schneider, R. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1605 · Cited by 629
Characterization of human high-density lipoproteins by gradient gel electrophoresis
Blanche, P. J., Gong, E. L., Forte, T. M., & Nichols, A. V. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90253-8 · Cited by 614
Garvey, W. T., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A., Pugh, K., Jenkins, A. J., Klein, R. L., & Liao, Y. (2003) · Diabetes · doi:10.2337/diabetes.52.2.453 · Cited by 607
Rubins, H. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2597 · Cited by 586
Chait, A., Brazg, R. L., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554
Self-citationGrundy, S. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.14.1568 · Cited by 551
Griffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J., & Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90129-5 · Cited by 525
[24] Nondenaturing polyacrylamide gradient gel electrophoresis
Nichols, A. V., Krauss, R. M., & Musliner, T. A. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)28084-2 · Cited by 521
Self-citationLow density lipoprotein particle size and coronary artery disease.
Campos, H., Genest, J. J., Blijlevens, E., McNamara, J. R., Jenner, J. L., Ordovas, J. M., Wilson, P. W., & Schaefer, E. J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.2.187 · Cited by 509
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
Kelley, D. E., & Simoneau, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117600 · Cited by 487
Tribble, D. L., Holl, L. G., Wood, P. D., & Krauss, R. M. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90255-f · Cited by 467
Self-citationHaffner, S. M., Mykkänen, L., Festa, A., Burke, J. P., & Stern, M. P. (2000) · Circulation · doi:10.1161/01.cir.101.9.975 · Cited by 457
Blake, G. J., Otvos, J. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000033222.75187.b9 · Cited by 409
McNamara, J. R., Campos, H., Ordovas, J. M., Peterson, J., Wilson, P. W., & Schaefer, E. J. (1987) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.7.5.483 · Cited by 383
Einhorn, D., Rendell, M., Rosenzweig, J., Egan, J. W., Mathisen, A. L., & Schneider, R. L. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)83039-8 · Cited by 368
Studies of low density lipoprotein molecular weight in human beings with coronary artery disease.
Crouse, J. R., Parks, J. S., Schey, H. M., & Kahl, F. R. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34343-1 · Cited by 312
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol
Robins, S. J., Rubins, H. B., Faas, F. H., Schaefer, E. J., Elam, M. B., Anderson, J. W., Collins, D., & on behalf of the VA-HIT Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1513 · Cited by 308
Rosenson, R. S., Otvos, J. D., & Freedman, D. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02427-x · Cited by 293
Coresh, J., Kwiterovich, P., Smith, H., & Bachorik, P. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35731-x · Cited by 290
Kipnes, M. S., Krosnick, A., Rendell, M. S., Egan, J. W., Mathisen, A. L., & Schneider, R. L. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00713-6 · Cited by 281
Change in LDL particle size is associated with change in plasma triglyceride concentration.
McNamara, J. R., Jenner, J. L., Li, Z., Wilson, P. W., & Schaefer, E. J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1284 · Cited by 275
Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1114 · Cited by 274
Vakkilainen, J., Steiner, G., Ansquer, J.-C., Aubin, F., Rattier, S., Foucher, C., Hamsten, A., & Taskinen, M.-R. (2003) · Circulation · doi:10.1161/01.cir.0000057982.50167.6e · Cited by 270
Wolffenbuttel, B. H. R., Gomis, R., Squatrito, S., Jones, N. P., & Patwardhan, R. N. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00224.x · Cited by 264
Zambon, A., Hokanson, J. E., Brown, B. G., & Brunzell, J. D. (1999) · Circulation · doi:10.1161/01.cir.99.15.1959 · Cited by 263
Athyros, V. G., Papageorgiou, A. A., Athyrou, V. V., Demitriadis, D. S., & Kontopoulos, A. G. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1198 · Cited by 257
Effect of 6-month adherence to a very low carbohydrate diet program
Westman, E. C., Yancy, W. S., Edman, J. S., Tomlin, K. F., & Perkins, C. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01129-4 · Cited by 252
Effect of hepatic lipase on LDL in normal men and those with coronary artery disease.
Zambon, A., Austin, M. A., Brown, B. G., Hokanson, J. E., & Brunzell, J. D. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.147 · Cited by 249
Freed, M. I., Ratner, R., Marcovina, S. M., Kreider, M. M., Biswas, N., Cohen, B. R., & Brunzell, J. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02659-0 · Cited by 238
Anber, V., Griffin, B. A., McConnell, M., Packard, C. J., & Shepherd, J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05842-x · Cited by 238
Björnheden, T., Babyi, A., Bondjers, G., & Wiklund, O. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05770-6 · Cited by 230
Atherogenicity of Triglyceride-Rich Lipoproteins
Krauss, R. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00032-0 · Cited by 227
Self-citationRosenblatt, S., Miskin, B., Glazer, N. B., Prince, M. J., & Robertson, K. E. (2001) · Coronary Artery Disease · doi:10.1097/00019501-200108000-00011 · Cited by 221
Williams, P. T., Krauss, R. M., Vranizan, K. M., & Wood, P. D. (1990) · Circulation · doi:10.1161/01.cir.81.4.1293 · Cited by 206
Self-citationManagement of Dyslipidemia in Adults With Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s83 · Cited by 203
Chu, N. V., Kong, A. P. S., Kim, D. D., Armstrong, D., Baxi, S., Deutsch, R., Caulfield, M., Mudaliar, S. R., Reitz, R., Henry, R. R., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.542 · Cited by 196
Guérin, M., Bruckert, E., Dolphin, P. J., Turpin, G., & Chapman, M. J. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.6.763 · Cited by 195
Rosenstock, J., Einhorn, D., Hershon, K., Glazer, N., & Yu, S. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11251.x · Cited by 193
Pascot, A., Lemieux, I., Prud'homme, D., Tremblay, A., Nadeau, A., Couillard, C., Bergeron, J., Lamarche, B., & Després, J.-P. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31529-7 · Cited by 185
Galeano, N. F., Milne, R., Marcel, Y. L., Walsh, M. T., Levy, E., Ngu'yen, T. D., Gleeson, A., Arad, Y., Witte, L., & al-Haideri, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42379-9 · Cited by 181
Lamarche, B., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Després, J.-P. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1098 · Cited by 170
Mechanism of action of niacin on lipoprotein metabolism
Kamanna, V. S., & Kashyap, M. L. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0093-1 · Cited by 163
Pavo, I., Jermendy, G., Varkonyi, T. T., Kerenyi, Z., Gyimesi, A., Shoustov, S., Shestakova, M., Herz, M., Johns, D., Schluchter, B. J., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021786 · Cited by 163
Miller, B. D., Alderman, E. L., Haskell, W. L., Fair, J. M., & Krauss, R. M. (1996) · Circulation · doi:10.1161/01.cir.94.9.2146 · Cited by 162
Self-citationVega, G. L., Ma, P. T. S., Cater, N. B., Filipchuk, N. G., Meguro, S., García-García, A.-B., & Grundy, S. M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00111-5 · Cited by 159
Ruotolo, G., Ericsson, C.-G., Tettamanti, C., Karpe, F., Grip, L., Svane, B., Nilsson, J., de Faire, U., & Hamsten, A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00442-2 · Cited by 158
Triglycerides and atherogenic lipoproteins: rationale for lipid management
Krauss, R. M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00213-7 · Cited by 146
Self-citationLamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05653-x · Cited by 144
Tan, C. E., Forster, L., Caslake, M. J., Bedford, D., Watson, T. D. G., McConnell, M., Packard, C. J., & Shepherd, J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1839 · Cited by 137
Tack, C. J., Smits, P., Demacker, P. N., & Stalenhoef, A. F. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.796 · Cited by 135
Syvänne, M., Ahola, M., Lahdenperä, S., Kahri, J., Kuusi, T., Virtanen, K. S., & Taskinen, M. R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39891-6 · Cited by 133
Frost, R. J., Otto, C., Geiss, H. C., SCHWANDT, P., & Parhofer, K. G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01270-4 · Cited by 127
McKenney, J. M., McCormick, L. S., Schaefer, E. J., Black, D. M., & Watkins, M. L. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01639-3 · Cited by 123
Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects.
Watson, T. D., Caslake, M. J., Freeman, D. J., Griffin, B. A., Hinnie, J., Packard, C. J., & Shepherd, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.6.902 · Cited by 122
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Holl, L. G., Krauss, R. M., Williams, P. T., Superko, H. R., Haskell, W. L., Alderman, E. L., Patricia, J., & Blanche, P. J. (2015) · Cited by 122
Self-citationZambon, A., Deeb, S. S., Brown, B. G., Hokanson, J. E., & Brunzell, J. D. (2001) · Circulation · doi:10.1161/01.cir.103.6.792 · Cited by 114
Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes
Gómez‐Perez, F. J., Fanghänel‐Salmón, G., Antonio Barbosa, J., Montes‐Villarreal, J., Berry, R. A., Warsi, G., & Gould, E. M. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.264 · Cited by 113
Differences in Receptor Binding of LDL Subfractions
Campos, H., Arnold, K. S., Balestra, M. E., Innerarity, T. L., & Krauss, R. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.6.794 · Cited by 112
Self-citationCombination therapy for dyslipidemia: safety and regulatory considerations
Davidson, M. H. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02970-3 · Cited by 105
Winkler, K., Konrad, T., Füllert, S., Friedrich, I., Destani, R., Baumstark, M. W., Krebs, K., Wieland, H., & März, W. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2588 · Cited by 104
Hopkins, G. J., & Barter, P. J. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38740-x · Cited by 103
Reaven, G. M., & Chen, Y. I. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90402-0 · Cited by 89
Atherogenic lipoprotein phenotype in Type 2 diabetes: reversal with micronised fenofibrate
Feher, M. D., Caslake, M., Foxton, J., Cox, A., & Packard, C. J. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199911/12)15:6<395::aid-dmrr65>3.0.co;2-n · Cited by 81
Blüher, M., Kratzsch, J., & Paschke, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.328 · Cited by 75
Krauss, R. M., Williams, P. T., Lindgren, F. T., & Wood, P. D. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.2.155 · Cited by 65
Self-citationMechanism of action of fibrates.
Shepherd, J. (1993) · PubMed · Cited by 57
Guerin, M., Le Goff, W., Frisdal, E., Schneider, S., Milosavljevic, D., Bruckert, E., & Chapman, M. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030191 · Cited by 51
Yuan, J., Tsaic, M. Y., & Hunninghake, D. B. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90062-0 · Cited by 50
Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism.
Fredenrich, A. (1998) · PubMed · Cited by 45
Vakkilainen, J., Steiner, G., Ansquer, J.-C., Perttunen-Nio, H., & Taskinen, M.-R. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.627 · Cited by 40
Lipoprotein Effects of Different Thiazolidinediones in Clinical Practice
Ovalle, F., & Bell, D. S. H. (2002) · Endocrine Practice · doi:10.4158/ep.8.6.406 · Cited by 28
St‐Pierre, A., Bergeron, J., Pirro, M., Cantin, B., Dagenais, G. R., Després, J., & Lamarche, B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03305-2 · Cited by 28
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“being less atheroprotective and the latter more atherogenic [216].”
BackgroundA comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
“The paracrine action would further tend to exacerbate the FFA release, inducing an atherogenic dyslipidemia [45].”
BackgroundRetractedBorén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationJellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Goldberg, R. B., Kendall, D. M., Deeg, M. A., Buse, J. B., Zagar, A. J., Pinaire, J. A., Tan, M. H., Khan, M. A., Perez, A. T., Jacober, S. J., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1547 · Cited by 795
Metadata
- Authors
- Krauss, R. M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2004-06-01
- Volume
- 27
- Issue
- 6
- Pages
- 1496-1504
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2105362864
- Cited by
- 756
- References
- 101
- FWCI
- 31.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.